|
Synonyms: compound B201 [WO2023220640]
Compound class:
Synthetic organic
Comment: Reziciclideg is the INN for a cyclin-dependent kinase degrader that was included in WHO INN Proposed List 135 (July 2026). Its structure suggests that it engages the cereblon (CRBN) E3 ubiquitin ligase. The compound is proposed as an antineoplastic agent. Note that the structure here has no specified stereo and is intended to represent the racemic mixture of isomers of the compound. The chemical structure is claimed in BioTheryX patents, for action as a CDK4/6 degrader [1-2]. Reziciclideg is predicted to be the INN for BioTheryX lead CDK4/6 PROTAC BTX-9341.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Ligand families/groups | PROTACs, molecular glues and other degraders |
IUPAC Name ![]() |
| 3-[4-[4-[2-[1-[6-[(6-acetyl-8-cyclopentyl-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]piperidin-4-yl]ethyl]piperazin-1-yl]phenyl]piperidine-2,6-dione |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 14273 | reziciclideg |
Synonyms ![]() |
| compound B201 [WO2023220640] |
Database Links ![]() |
|
| CAS Registry No. | 3011828-23-9 (source: WHO INN record) |
| GtoPdb PubChem SID | 530846874 |
| PubChem CID | 176885913 |
| Search Google for chemical match using the InChIKey | CSBZXBPFGOKMKW-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | CSBZXBPFGOKMKW |
| Search PubMed clinical trials | reziciclideg |
| Search PubMed titles | reziciclideg |
| Search PubMed titles/abstracts | reziciclideg |
| UniChem Compound Search for chemical match using the InChIKey | CSBZXBPFGOKMKW-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | CSBZXBPFGOKMKW-UHFFFAOYSA-N |